Godavari Biorefineries Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹549 Cr +27.4% YoYSee revenue, profit and what management said. You are viewing Q1 FY27.
GB

Godavari Biorefineries Ltd

Q1 FY27Diversified FMCG

Godavari Biorefineries Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Revenue
₹558Cr
+4.7% YoY
−1.1% QoQ
Net profit
−₹19Cr
Q1 FY26: −₹16 Cr
Margin
0.1%
−1 pp YoY
−14.9 pp QoQ

What the Q1 FY27 call signalled

1 of 4 strong

RevenueModerate growth
MarginMargins slightly down
CapexCapex planned
FundraiseNo fundraise planned
Price₹243
Market cap₹1.2K Cr
P/E42.5

The short version

Expecting strong growth in bio-based specialty chemicals with sales projected to increase from INR190 crores in the current quarter to INR240 crores per quarter post INR25 crores debottlenecking investment by early FY28. Bio-based specialty chemicals business shows strong growth with revenue increasing QoQ from INR141 crores to INR190 crores, expected to reach INR240 crores per quarter post-debottlenecking by early FY28.

From Godavari Biorefineries Ltd's Q1 FY27 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

Moderate growth
  • Expecting strong growth in bio-based specialty chemicals with sales projected to increase from INR190 crores in the current quarter to INR240 crores per quarter post INR25 crores debottlenecking investment by early FY28.
  • Operating cash flows in the chemical sector expected to improve and sustain due to better gross margins and debottlenecking benefits.
  • Ethanol demand anticipated to grow with E20 rollout continuing and introduction of E85 and E100 fuels, supported by government policies and flex-fuel vehicles.
  • Investing in additional maize/grain front-end capacity to optimize product mix and improve ethanol production flexibility.

2 more points from Godavari Biorefineries Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Godavari Biorefineries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Immediate investment of INR 25 crores planned for debottlenecking the bio-based specialty chemical business to meet growing demand, expected to complete by early FY28.
  • Exploring front-end investments in maize/grain preparation facilities to utilize idle fermentation and distillation capacity, potentially adding 160 KLPD fungible capacity within the existing 800 KLPD distillery.
  • Committed to spending INR 20 crores over the next 30-33 months on drug discovery, including safety trials for a novel anticancer molecule.

2 more points from Godavari Biorefineries Ltd's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what Godavari Biorefineries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The company is experiencing strong and growing demand in its bio-based specialty chemicals business both domestically and internationally.
  • They are expecting sales of about INR 190 crores in the current quarter, up from INR 169 crores reported last quarter.
  • Post completion of a planned INR 25 crore debottlenecking investment (expected by the start of FY28), they anticipate bio-based specialty chemicals business to reach around INR 240 crores per quarter.
  • There is significant customer interest fueled by global supply tightness and increased focus on supply chain reliability.

Godavari Biorefineries Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Godavari Biorefineries Ltd Q1 FY27 results — key figures

Godavari Biorefineries Ltd Q1 FY27 reported results vs Q1 FY26, ₹ crore
₹ CrQ1 FY27Q1 FY26YoYQ4 FY26QoQ
Revenue558533+4.7%564-1.1%
Operating profit (EBITDA)16-83.3%86-98.8%
Operating margin0.1%1.1%-1 pp15%-14.9 pp
Profit before tax-26-22—70-137.1%
Net profit (PAT)-19-16—53-135.8%
EPS (₹)-3.78-3.13—10.33-136.6%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹549 Cr, net loss ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Godavari Biorefineries Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Godavari Biorefineries Ltd Q1 FY27 results?

Expecting strong growth in bio-based specialty chemicals with sales projected to increase from INR190 crores in the current quarter to INR240 crores per quarter post INR25 crores debottlenecking investment by early FY28. Bio-based specialty chemicals business shows strong growth with revenue increasing QoQ from INR141 crores to INR190 crores, expected to reach INR240 crores per quarter post-debottlenecking by early FY28.

What is Godavari Biorefineries Ltd share price analysis?

Godavari Biorefineries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 42.5 with a market cap of ₹1,233 Cr. Investors should review the full earnings analysis for detailed insights.

Is Godavari Biorefineries Ltd planning capital expenditure?

Immediate investment of INR 25 crores planned for debottlenecking the bio-based specialty chemical business to meet growing demand, expected to complete by early FY28.

Keep Godavari Biorefineries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.